OTLK:Outlook Therapeutics Inc Snapshot | Charting | News | Options
$7.78 NASDAQ 5:00p ET
May 15 '24 		Outlook Therapeutics(R) Reports Financial Results for Second Quarter Fiscal Year 2024 and Provides Corpora... GlobeNewswire
Last  Change Exchange
Market data is delayed by at least 15 minutes.
Markets Portfolio
    Symbol Lookup
    Latest Story Top Stories on OTLK
    No News Available
    Outlook Therapeutics(R) Announces UK Submission of Marketing Authoriz...
    8:50a ET May 13 '24 GlobeNewswire
    Outlook Therapeutics(R) to Report Financial Results for Second Quarte...
    8:45a ET May 9 '24 GlobeNewswire
    Outlook Therapeutics(R) to Present at the Retina World Congress 2024
    9:05a ET May 2 '24 GlobeNewswire
    Outlook Therapeutics(R) to Present at the Ophthalmology Innovation Su...
    9:00a ET April 29 '24 GlobeNewswire
    Outlook Therapeutics(R) Announces Closing of Private Placement of $5....
    4:15p ET April 15 '24 GlobeNewswire
    Outlook Therapeutics(R) Receives European Union Positive CHMP Opinion...
    7:36a ET March 22 '24 GlobeNewswire
    Outlook Therapeutics(R) Announces Closing of Private Placement of up ...
    5:10p ET March 18 '24 GlobeNewswire
    Thinking about buying stock in Mind Medicine, Ocean Biomedical, Arche...
    9:45a ET March 15 '24 PR Newswire
    Outlook Therapeutics(R) Announces Effective Date for 1-for-20 Reverse...
    8:05a ET March 12 '24 GlobeNewswire

    Market data provided by News provided by


    This site is published in the United States for U.S. residents only. The services offered within this site are available exclusively through our U.S. Financial Advisors. Stifel Nicolaus Financial Advisors may only conduct business with residents of the state in which they are properly registered. The information on this website is not an offer to sell or a solicitation of an offer to buy, any security, nor shall any such security be offered or sold to any person in any jurisdiction in which such offer, solicitation, purchase or sale may not lawfully be made.
    Important Disclosures | Privacy Notice | HIPAA Policy | Use of Information Policy | Business Continuity | Canada Trade Matching Statement

    Stifel, Nicolaus & Co., Inc. Member NYSE, FINRA, and SIPC.
    Stifel Nicolaus Canada Inc., is a member of CIPF/FCPE and IIROC
    Copyright © 2024 All rights reserved.